Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

373

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions
Asthma
Interventions
DRUG

Epinephrine inhalation aerosol

Epinephrine inhalation aerosol, 125 mcg/inhalation, 2 inhalations QID at 4 - 6 hour intervals

DRUG

Placebo

Placebo for epinephrine inhalation aerosol, formulation without epinephrine

DRUG

epinephrine inhalation aerosol

epinephrine inhalation aerosol, 220 mcg/inhalation, 2 inhalations QID at 4-6 hour intervals

Trial Locations (33)

15241

Allergy and Clinical Immunology Associates, Pittsburgh

17013

Asthma & Allergy Research Associates, Upland

23229

Allergy Partners, Richmond

27607

North Carolina Clinical Research, Raleigh

29406

National Allergy, Asthma & Urticaria Centers of Charleston, Charleston

30188

Atlanta Allergy & Asthma Clinic, Woodstock

40215

Family Allergy & Asthma Research Institute, Louisville

45242

New Horizons Clinical Research, Cincinnati

52240

Iowa Clinical Research Corporation, Iowa City

55402

Clinical Research Institute, Minneapolis

55441

Clinical Research Institute, Plymouth

59718

Clinical Research Group of Montana, Bozeman

63141

The Clinical Research Center, St Louis

68123

The Asthma & Allergy Center, Bellevue

78130

Central Texas Health Research, New Braunfels

78229

Sylvana Research Associates, San Antonio

79903

Western Sky Research, El Paso

80033

Rocky Mountain Center for Clinical Research, Wheat Ridge

80112

Colorado Allergy & Asthma Centers, Centennial

80230

Colorado Allergy & Asthma Centers, Denver

90048

Southern California Institute for Respiratory Diseases, Los Angeles

92626

West Coast Clinical Trials, Costa Mesa

92691

Asthma and Allergy Associates of Southern California, Mission Viejo

92868

CHOC PSF, Division of Allergy, Asthma and Immunology, Orange

95117

Allergy & Asthma Assocaites of Santa Clara Valley, San Jose

97035

Baker Allergy, Asthma & Dermatology Research Center, Lake Oswego

97213

Transitional Clinical Research, Portland

97401

Allergy and Asthma Research Group, Eugene

97504

The Clinical Research Institute of Southern Oregon, Medford

97520

Intergated Medical Research, Ashland

98105

ASTHMA, Inc., Seattle

02747

Northeast Medical Research Associates, No. Dartmouth

08558

Princeton Center for Clinical Research, Skillman

All Listed Sponsors
lead

Amphastar Pharmaceuticals, Inc.

INDUSTRY

NCT01357642 - Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients | Biotech Hunter | Biotech Hunter